Public Company Disclosures in Light of COVID-19
The spread of the coronavirus continues to spread globally, public companies are facing a myriad of questions and uncertainty as they begin to prepare first quarter reports. In our webinar we discussed liability considerations and advice on disclosure considerations as we navigate these uncertain times. By early March, companies were taking different approaches. We saw that companies that have significant operations or supply chains involving China, or that are particularly vulnerable to the impact of COVID-19, were including more tailored disclosures. Additionally, they began including COVID-19-related disclosures in their MD&A that were customized for their business and industry. We discussed these and other disclosure trends and provided practical guidance around the decision making process about what to disclose.